PNEUMOCOCCAL VACCINE POLYVALENT: 401 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
401
Total FAERS Reports
9 (2.2%)
Deaths Reported
166
Hospitalizations
401
As Primary/Secondary Suspect
11
Life-Threatening
30
Disabilities
First Report: 2008 · Latest Report: 20250612
What Are the Most Common PNEUMOCOCCAL VACCINE POLYVALENT Side Effects?
#1 Most Reported
Dyspnoea
105 reports (26.2%)
#2 Most Reported
Pyrexia
80 reports (20.0%)
#3 Most Reported
Asthma
80 reports (20.0%)
All PNEUMOCOCCAL VACCINE POLYVALENT Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 105 | 26.2% | 1 | 64 |
| Asthma | 80 | 20.0% | 1 | 51 |
| Pyrexia | 80 | 20.0% | 1 | 32 |
| Drug ineffective | 67 | 16.7% | 4 | 25 |
| Chronic obstructive pulmonary disease | 65 | 16.2% | 1 | 51 |
| Fatigue | 58 | 14.5% | 3 | 20 |
| Cough | 56 | 14.0% | 0 | 26 |
| Wheezing | 56 | 14.0% | 1 | 47 |
| Hypertension | 55 | 13.7% | 1 | 38 |
| Gastrooesophageal reflux disease | 50 | 12.5% | 1 | 42 |
| Productive cough | 50 | 12.5% | 1 | 33 |
| Therapeutic product effect incomplete | 50 | 12.5% | 1 | 41 |
| Bronchiectasis | 48 | 12.0% | 1 | 41 |
| Pain | 47 | 11.7% | 1 | 21 |
| Headache | 44 | 11.0% | 3 | 15 |
| Obstructive airways disorder | 42 | 10.5% | 1 | 40 |
| Loss of personal independence in daily activities | 41 | 10.2% | 0 | 28 |
| Arthralgia | 40 | 10.0% | 2 | 12 |
| Dyspnoea exertional | 38 | 9.5% | 1 | 36 |
| Breath sounds abnormal | 37 | 9.2% | 1 | 32 |
Who Reports PNEUMOCOCCAL VACCINE POLYVALENT Side Effects? Age & Gender Data
Gender: 51.7% female, 48.3% male. Average age: 57.4 years. Most reports from: US. View detailed demographics →
Is PNEUMOCOCCAL VACCINE POLYVALENT Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2008 | 3 | 0 | 3 |
| 2010 | 1 | 0 | 0 |
| 2011 | 2 | 0 | 1 |
| 2012 | 2 | 0 | 1 |
| 2013 | 12 | 0 | 4 |
| 2014 | 16 | 0 | 9 |
| 2015 | 25 | 0 | 7 |
| 2016 | 14 | 2 | 5 |
| 2017 | 18 | 0 | 8 |
| 2018 | 13 | 0 | 7 |
| 2019 | 17 | 0 | 9 |
| 2020 | 29 | 1 | 13 |
| 2021 | 13 | 0 | 1 |
| 2022 | 12 | 0 | 6 |
| 2023 | 19 | 0 | 6 |
| 2024 | 11 | 0 | 1 |
| 2025 | 8 | 0 | 2 |
What Is PNEUMOCOCCAL VACCINE POLYVALENT Used For?
| Indication | Reports |
|---|---|
| Immunisation | 140 |
| Product used for unknown indication | 125 |
| Prophylaxis | 80 |
| Pneumococcal immunisation | 9 |
| Pneumonia | 8 |
| Pneumococcal infection | 5 |
PNEUMOCOCCAL VACCINE POLYVALENT vs Alternatives: Which Is Safer?
PNEUMOCOCCAL VACCINE POLYVALENT vs PNEUMOCOCCAL VACCINE, POLYVALENT 23
PNEUMOCOCCAL VACCINE POLYVALENT vs POLATUZUMAB VEDOTIN
PNEUMOCOCCAL VACCINE POLYVALENT vs POLATUZUMAB VEDOTIN-PIIQ
PNEUMOCOCCAL VACCINE POLYVALENT vs POLIDOCANOL
PNEUMOCOCCAL VACCINE POLYVALENT vs POLYETHYLENE GLYCOL
PNEUMOCOCCAL VACCINE POLYVALENT vs POLYETHYLENE GLYCOL 3350
PNEUMOCOCCAL VACCINE POLYVALENT vs POLYETHYLENE GLYCOL 3350\POTASSIUM\SODIUM BICARBONATE\SODIUM
PNEUMOCOCCAL VACCINE POLYVALENT vs POLYETHYLENE GLYCOL 3350\POTASSIUM\SODIUM BICARBONATE\SODIUM\SODIUM
PNEUMOCOCCAL VACCINE POLYVALENT vs POLYETHYLENE GLYCOL 3350\POTASSIUM\SODIUM BICARBONATE\SODIUM\SODIUM ANHYDROUS
PNEUMOCOCCAL VACCINE POLYVALENT vs POLYETHYLENE GLYCOL 400
Official FDA Label for PNEUMOCOCCAL VACCINE POLYVALENT
Official prescribing information from the FDA-approved drug label.